Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

A Prospective, Observational Study of Conversion From Immediate- to Prolonged-Release Tacrolimus in Renal Transplant Recipients in France: The OPALE Study.

Moal V, Grimbert P, Beauvais A, Dubel L, Le Meur Y.

Ann Transplant. 2019 Sep 3;24:517-526. doi: 10.12659/AOT.916043.

2.

Simultaneous cytomegalovirus glomerulitis and BK virus nephropathy leading to kidney allograft loss.

Moktefi A, Kofman T, Sakhi H, Matignon M, Grimbert P.

Pathology. 2019 Oct;51(6):641-644. doi: 10.1016/j.pathol.2019.05.007. Epub 2019 Aug 27. No abstract available.

PMID:
31470994
3.

Extracorporeal photopheresis for the treatment of graft rejection in 33 adult kidney transplant recipients.

Tamain M, Sayegh J, Lionet A, Grimbert P, Philipponnet C, Hazzan M, Augusto JF, Büchler M, Merlin E, Kosmadakis G, Tiple A, Pereira B, Garrouste C, Heng AE.

Transfus Apher Sci. 2019 Aug;58(4):515-524. doi: 10.1016/j.transci.2019.06.031. Epub 2019 Jul 22.

PMID:
31383541
4.

Survival and specific outcome of sickle cell disease patients after renal transplantation.

Gérardin C, Moktefi A, Couchoud C, Duquesne A, Ouali N, Gataut P, Karras A, Anglicheau D, Lefaucheur C, Figueres L, Albano L, Lionet A, Novion M, Ziliotis MJ, Louis M, Del Bello A, Matignon M, Dahan K, Habibi A, Galacteros F, Bartolucci P, Grimbert P, Audard V.

Br J Haematol. 2019 Jul 26. doi: 10.1111/bjh.16113. [Epub ahead of print]

PMID:
31348518
5.

Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.

Kwun J, Matignon M, Manook M, Guendouz S, Audard V, Kheav D, Poullot E, Gautreau C, Ezekian B, Bodez D, Damy T, Faivre L, Menouch D, Yoon J, Park J, Belhadj K, Chen D, Bilewski AM, Yi JS, Collins B, Stegall M, Farris AB, Knechtle S, Grimbert P.

J Am Soc Nephrol. 2019 Jul;30(7):1206-1219. doi: 10.1681/ASN.2018121254. Epub 2019 Jun 21.

PMID:
31227636
6.

[Evaluation of single kidney graft outcome in patients initially programmed for a dual kidney graft transplantation].

Merzeau N, Champy C, Such M, Klapp J, Chahwan C, Vordos D, Hoznek A, Matignon M, Grimbert P, de la Taille A, Salomon L.

Prog Urol. 2019 May - Jun;29(6):340-346. doi: 10.1016/j.purol.2019.04.003. French.

PMID:
31151914
7.

Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study.

Attias P, Melica G, Boutboul D, De Castro N, Audard V, Stehlé T, Gaube G, Fourati S, Botterel F, Fihman V, Audureau E, Grimbert P, Matignon M.

J Clin Med. 2019 Apr 30;8(5). pii: E594. doi: 10.3390/jcm8050594.

8.

Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression.

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL.

Kidney Int. 2019 Jun;95(6):1471-1485. doi: 10.1016/j.kint.2018.12.029. Epub 2019 Mar 5.

PMID:
30955869
9.

Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives.

Leibler C, Thiolat A, Elsner RA, El Karoui K, Samson C, Grimbert P.

Kidney Int. 2019 Apr;95(4):774-786. doi: 10.1016/j.kint.2018.10.028. Epub 2019 Jan 31. Review.

PMID:
30711200
10.

Low incidence of acute rejection within 6 months of kidney transplantation in HIV-infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial.

Matignon M, Lelièvre JD, Lahiani A, Abbassi K, Desvaux D, Diallo A, Peraldi MN, Taburet AM, Saillard J, Delaugerre C, Costagliola D, Assoumou L, Grimbert P; ANRS 153 TREVE study group.

HIV Med. 2019 Mar;20(3):202-213. doi: 10.1111/hiv.12700. Epub 2019 Jan 27.

PMID:
30688008
11.

Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR).

Leibler C, Matignon M, Moktefi A, Samson C, Zarour A, Malard S, Boutin E, Pilon C, Salomon L, Natella PA, Durrbach A, Robert T, Canoui-Poitrine F, Grimbert P.

Am J Transplant. 2019 Mar;19(3):894-906. doi: 10.1111/ajt.15229. Epub 2019 Jan 25.

PMID:
30582270
12.

Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring.

Leibler C, Moktefi A, Matignon M, Debiais-Delpech C, Oniszczuk J, Sahali D, Cohen JL, Grimbert P, Audard V.

J Clin Med. 2018 Nov 9;7(11). pii: E430. doi: 10.3390/jcm7110430.

13.

An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).

Rémy P, Audard V, Natella PA, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Ait Sahlia N, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D; MSN Trial Investigators.

Kidney Int. 2018 Dec;94(6):1217-1226. doi: 10.1016/j.kint.2018.07.021. Epub 2018 Oct 29.

PMID:
30385039
14.

Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.

Rousseau B, Guillemin A, Duvoux C, Neuzillet C, Tlemsani C, Compagnon P, Azoulay D, Salloum C, Laurent A, de la Taille A, Salomon L, Cholley I, Haioun C, Dupuis J, Wolkenstein P, Matignon MB, Grimbert P, Tournigand C.

Int J Cancer. 2019 Feb 15;144(4):886-896. doi: 10.1002/ijc.31769. Epub 2018 Nov 20.

PMID:
30155929
15.

Renal artery fibromuscular dysplasia in Pompe disease: A case report.

Pappa E, Papadopoulos C, Grimbert P, Laforêt P, Bassez G.

Mol Genet Metab Rep. 2018 Jul 26;16:64-65. doi: 10.1016/j.ymgmr.2018.07.002. eCollection 2018 Sep.

16.

[Current insights about recurrence of glomerular diseases after renal transplantation].

Kofman T, Oniszczuk J, Lang P, Grimbert P, Audard V.

Nephrol Ther. 2018 May;14(3):179-188. doi: 10.1016/j.nephro.2018.03.001. Epub 2018 Apr 26. Review. French.

PMID:
29706414
17.

Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey.

Gauthier M, Canoui-Poitrine F, Guéry E, Desvaux D, Hue S, Canaud G, Stehle T, Lang P, Kofman T, Grimbert P, Matignon M.

Nephrol Dial Transplant. 2018 Apr 1;33(4):709-716. doi: 10.1093/ndt/gfx353.

PMID:
29346631
18.

Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk.

Leibler C, Thiolat A, Hénique C, Samson C, Pilon C, Tamagne M, Pirenne F, Vingert B, Cohen JL, Grimbert P.

J Am Soc Nephrol. 2018 Mar;29(3):1049-1062. doi: 10.1681/ASN.2017060679. Epub 2018 Jan 10.

19.

Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation.

Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M.

Transplantation. 2018 Apr;102(4):688-698. doi: 10.1097/TP.0000000000002002.

PMID:
29135832
20.

Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats.

Hamdani S, Thiolat A, Naserian S, Grondin C, Moutereau S, Hulin A, Calderaro J, Grimbert P, Cohen JL, Azoulay D, Pilon C.

World J Gastroenterol. 2017 Oct 14;23(38):6962-6972. doi: 10.3748/wjg.v23.i38.6962.

21.

Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study.

Kofman T, Pourcine F, Canoui-Poitrine F, Kamar N, Malvezzi P, François H, Boutin E, Audard V, Lang P, Martinez F, Legendre C, Matignon M, Grimbert P.

Transpl Int. 2018 Apr;31(4):377-385. doi: 10.1111/tri.13078. Epub 2017 Oct 12.

22.

Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.

Matignon M, Pilon C, Commereuc M, Grondin C, Leibler C, Kofman T, Audard V, Cohen J, Canoui-Poitrine F, Grimbert P.

PLoS One. 2017 Jun 27;12(6):e0178572. doi: 10.1371/journal.pone.0178572. eCollection 2017.

23.

Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study.

Normand G, Brunner F, Badet L, Buron F, Catton M, Massardier J, Esposito L, Grimbert P, Mourad G, Serre JE, Caillard S, Karam G, Cantarovich D, Morelon E, Thaunat O.

Transpl Int. 2017 Sep;30(9):893-902. doi: 10.1111/tri.12983. Epub 2017 Jun 15.

24.

Toward a better risk stratification for late antibody-mediated rejection in ABO incompatible kidney recipients.

Grimbert P.

Transpl Int. 2017 Sep;30(9):863-864. doi: 10.1111/tri.12976. No abstract available.

25.

mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now?

Grimbert P, Thaunat O.

Transpl Int. 2017 Jul;30(7):647-657. doi: 10.1111/tri.12975. Review.

26.

Facial transplantation: facing the limits, planning the future.

Lantieri L, Grimbert P, Ortonne N, Lemogne C, Wolkenstein P, Hivelin M.

Lancet. 2017 Apr 1;389(10076):1293-1294. doi: 10.1016/S0140-6736(17)30831-0. No abstract available.

PMID:
28379144
27.

Opioids and nonopioids for postoperative pain control in patients with chronic kidney disease.

Binhas M, Egbeola-Martial J, Kluger MD, Roudot-Thoraval F, Grimbert P.

J Opioid Manag. 2017 Jan/Feb;13(1):17-25. doi: 10.5055/jom.2017.0364.

PMID:
28345743
28.

[De novo cancer after solid organ transplantation: Epidemiology, prognosis and management].

Guillemin A, Rousseau B, Neuzillet C, Joly C, Boussion H, Grimbert P, Compagnon P, Duvoux C, Tournigand C.

Bull Cancer. 2017 Mar;104(3):245-257. doi: 10.1016/j.bulcan.2016.12.008. Epub 2017 Feb 23. Review. French.

PMID:
28237352
29.

C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.

Moktefi A, Parisot J, Desvaux D, Canoui-Poitrine F, Brocheriou I, Peltier J, Audard V, Kofman T, Suberbielle C, Lang P, Rondeau E, Grimbert P, Matignon M.

Transpl Int. 2017 Mar;30(3):277-287. doi: 10.1111/tri.12905.

30.

Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.

Deux JF, Audard V, Brugières P, Habibi A, Manea EM, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P.

Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.

PMID:
27663041
31.

Reversible kidney iron accumulation in a patient with sickle cell disease treated with hydroxyurea.

Stehlé T, Bartolucci P, Bouanane M, Galacteros F, Dudreuilh C, Grimbert P, Deux JF, Audard V.

Am J Hematol. 2016 Dec;91(12):1283-1284. doi: 10.1002/ajh.24544. Epub 2016 Oct 14. No abstract available.

32.

Face transplant: long-term follow-up and results of a prospective open study.

Lantieri L, Grimbert P, Ortonne N, Suberbielle C, Bories D, Gil-Vernet S, Lemogne C, Bellivier F, Lefaucheur JP, Schaffer N, Martin F, Meningaud JP, Wolkenstein P, Hivelin M.

Lancet. 2016 Oct 1;388(10052):1398-1407. doi: 10.1016/S0140-6736(16)31138-2. Epub 2016 Aug 25.

PMID:
27567680
33.

Monotypic plasma cell interstitial nephritis as the only clinical manifestation in a patient with previously undiagnosed indolent multiple myeloma: A case report.

Attias P, Moktefi A, Matignon M, Dupuis J, Debiais-Delpech C, Grimbert P, Lang P, Audard V.

Medicine (Baltimore). 2016 Aug;95(31):e4391. doi: 10.1097/MD.0000000000004391.

34.

DETRIMENTAL EFFECTS OF ACTIVE INTERNAL LIMITING MEMBRANE PEELING DURING EPIRETINAL MEMBRANE SURGERY: Microperimetric Analysis.

Deltour JB, Grimbert P, Masse H, Lebreton O, Weber M.

Retina. 2017 Mar;37(3):544-552. doi: 10.1097/IAE.0000000000001179.

PMID:
27429376
35.

Transcriptomic Signature of the CD24hi CD38hi Transitional B Cells Associated With an Immunoregulatory Phenotype in Renal Transplant Recipients.

Bigot J, Pilon C, Matignon M, Grondin C, Leibler C, Aissat A, Pirenne F, Cohen JL, Grimbert P.

Am J Transplant. 2016 Dec;16(12):3430-3442. doi: 10.1111/ajt.13904. Epub 2016 Jul 14.

36.

Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin.

Matignon M, Leibler C, Moranne O, Salomon L, Charron D, Lang P, Jacquelinet C, Suberbielle C, Grimbert P.

Clin Transplant. 2016 Jun;30(6):731-40. doi: 10.1111/ctr.12743. Epub 2016 May 2.

PMID:
27140447
37.

Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients.

Nielsen L, Canouï-Poitrine F, Jais JP, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V.

Br J Haematol. 2016 Jul;174(1):148-52. doi: 10.1111/bjh.14040. Epub 2016 Mar 17.

PMID:
26992059
38.

Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Thaunat O, Koenig A, Leibler C, Grimbert P.

J Am Soc Nephrol. 2016 Jul;27(7):1890-900. doi: 10.1681/ASN.2015070781. Epub 2016 Feb 12. Review.

39.

Successful Treatment of Lung Calciphylaxis With Sodium Thiosulfate in a Patient With Sickle Cell Disease: A Case Report.

Arrestier R, Dudreuilh C, Remy P, Boulahia G, Bentaarit B, Leibler C, Adedjouma A, Kofman T, Matignon M, Sahali D, Dufresne R, Deux JF, Colin C, Grimbert P, Lang P, Bartolucci P, Maitre B, Tran Van Nhieu J, Audard V.

Medicine (Baltimore). 2016 Feb;95(6):e2768. doi: 10.1097/MD.0000000000002768.

40.

B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.

Delville M, Baye E, Durrbach A, Audard V, Kofman T, Braun L, Olagne J, Nguyen C, Deschênes G, Moulin B, Delahousse M, Kesler-Roussey G, Beaudreuil S, Martinez F, Rabant M, Grimbert P, Gallazzini M, Terzi F, Legendre C, Canaud G.

J Am Soc Nephrol. 2016 Aug;27(8):2520-7. doi: 10.1681/ASN.2015091002. Epub 2015 Dec 23.

41.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V.

J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19.

42.

Prélèvement rénal de donneur vivant par laparoscopie robot-assistée avec extraction vaginale : mise à jour d'une série monocentrique.

Champy C, Salomon L, Cholley I, Hoznek A, Yiou R, Vordos D, Grimbert P, Lang P, De La Taille A.

Prog Urol. 2015 Nov;25(13):723. doi: 10.1016/j.purol.2015.08.016. French. No abstract available.

PMID:
26544211
43.

Bigreffe : un rein ou deux reins ? Une source potentielle de greffons supplémentaires.

Such M, Vordos D, Hoznek A, Cholley I, Masson-Lecomte A, Parier B, Grimbert P, Lang P, De La Taille A, Salomon L.

Prog Urol. 2015 Nov;25(13):721. doi: 10.1016/j.purol.2015.08.011. French. No abstract available.

PMID:
26544206
44.

Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy.

Patri P, Seshan SV, Matignon M, Desvaux D, Lee JR, Lee J, Dadhania DM, Serur D, Grimbert P, Hartono C, Muthukumar T.

Kidney Int. 2016 Feb;89(2):450-8.

45.

Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts.

Caillard S, Moulin B, Buron F, Mariat C, Audard V, Grimbert P, Marquet P.

Transpl Int. 2016 Aug;29(8):860-9. doi: 10.1111/tri.12674. Epub 2015 Sep 16. Review.

46.

Extensively burns patients are not unsuitable candidates to vascularized composite allotransplantations but require optimization in access to suitable transplants.

Hivelin M, Lantieri L, Suberbielle C, Jacquelinet C, Audry B, Grimbert P, Duhamel P.

J Plast Reconstr Aesthet Surg. 2015 Dec;68(12):1763-4. doi: 10.1016/j.bjps.2015.08.024. Epub 2015 Sep 3. No abstract available.

PMID:
26365149
47.

Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases.

Dauvergne M, Moktefi A, Rabant M, Vigneau C, Kofman T, Burtey S, Corpechot C, Stehlé T, Desvaux D, Rioux-Leclercq N, Rouvier P, Knebelmann B, Boffa JJ, Frouget T, Daugas E, Jablonski M, Dahan K, Brocheriou I, Remy P, Grimbert P, Lang P, Chazouilleres O, Sahali D, Audard V.

Medicine (Baltimore). 2015 Jul;94(30):e1243. doi: 10.1097/MD.0000000000001243.

48.

Extensively burned patients still need blood transfusions and skin allografts: unavoidable HLA sensitization requires optimization of VCA access.

Duhamel P, Suberbielle C, Grimbert P, Leclerc T, Jacquelinet C, Audry B, Bargues L, Charron D, Bey E, Lantieri L, Hivelin M.

Transpl Int. 2015 Oct;28(10):1229-30. doi: 10.1111/tri.12610. No abstract available.

49.

Th-17 Alloimmune Responses in Renal Allograft Biopsies From Recipients of Kidney Transplants Using Extended Criteria Donors During Acute T Cell-Mediated Rejection.

Matignon M, Aissat A, Canoui-Poitrine F, Grondin C, Pilon C, Desvaux D, Saadoun D, Barathon Q, Garrido M, Audard V, Rémy P, Lang P, Cohen J, Grimbert P.

Am J Transplant. 2015 Oct;15(10):2718-25. doi: 10.1111/ajt.13304. Epub 2015 May 18.

50.

Anti-HLA sensitization in extensively burned patients: extent, associated factors, and reduction in potential access to vascularized composite allotransplantation.

Duhamel P, Suberbielle C, Grimbert P, Leclerc T, Jacquelinet C, Audry B, Bargues L, Charron D, Bey E, Lantieri L, Hivelin M.

Transpl Int. 2015 May;28(5):582-93. doi: 10.1111/tri.12540. Epub 2015 Feb 26.

Supplemental Content

Loading ...
Support Center